Historically, polymeric solid dispersions have been the technology of choice for amorphous formulation. However, this approach may have some downfalls when considering the ability to stabilize compounds in the amorphous form, especially poor glass former compounds with a high propensity to re-crystallize. This webinar will examine amorphous stability from a theoretical perspective in the context of polymeric solid dispersions and mesoporous silica formulations. Finally, we will present recent data demonstrating the potential of mesoporous silica for superior amorphous stabilization of poor glass formers.
In this webinar, you will learn:
- Why amorphous stability is a critical consideration in formulation development for poorly soluble compounds
- How amorphous stability can be assessed using the glass-forming ability
- Why poor glass former compounds can be challenging to formulate with traditional polymeric solid dispersions
- How mesoporous silica can stabilize poor glass formers via nanoconfinement and reduction in molecular mobility
Speaker
Daniel Joseph Price, Ph.D.
Merck
Strategic Marketing Manager
Daniel Joseph Price is a strategic marketing manager for our portfolio of solubility enhancement excipients. Prior to his current role, Daniel was a Marie Curie Fellow, conducting research on solubility enhancement with amorphous formulations. Daniel is an active member of several academia/industrial consortia on the topics of innovation in oral solid dosage forms and has published extensively on the topic in peer-reviewed journals. Daniel has a B.S. and an M.S. in chemistry from the University of Leeds and a Ph.D. in pharmaceutical technology from Frankfurt Goethe University.
Pharma and biopharma manufacturing
- Solid Formulation Strategies
Duration:50min
語言:English
會話 1:提出 February 13, 2020
若要繼續閱讀，請登入或建立帳戶。
還沒有帳戶？